Scheen, A., Paquot, N., & Lefèbvre, P. (May 2023). L’hypoglycémie réactionnelle : un trouble fonctionnel fréquemment évoqué, mais surestimé en pratique clinique. Revue Médicale de Liège, 78 (5-6), 363-368. Editorial Reviewed verified by ORBi |
Scheen, A., & Lefèbvre, P. (February 2023). Glucagon, from past to present: a century of intensive research and controversies. The Lancet Diabetes and Endocrinology, 11 (2), 129-138. doi:10.1016/S2213-8587(22)00349-7 Peer Reviewed verified by ORBi |
SCHEEN, A., & Lefèbvre, P. (2021). L'épopée des insulines des années 1930 aux années 1980. Médecine des Maladies Métaboliques. doi:10.1016/S1957-2557(21)00177-2 Peer Reviewed verified by ORBi |
Scheen, A., Lefèbvre, P., & Paquot, N. (2018). La metformine revisitee : moins de restrictions et davantage d'indications. Revue Médicale de Liège, 73 (11), 544-549. Peer reviewed |
Scheen, A., Paquot, N., & Lefèbvre, P. (2017). Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes. Expert Opinion on Investigational Drugs, 26 (12), 1373-1389. doi:10.1080/13543784.2017.1395020 Peer Reviewed verified by ORBi |
SCHEEN, A., PAQUOT, N., & LEFEBVRE, P. (September 2016). La vignette diagnostique de l’étudiant Mise au point d’une suspicion de malaise hypoglycémique chez une personne adulte non diabétique. Revue Médicale de Liège, 71 (09), 407-413. Peer reviewed |
LEFEBVRE, P., Paquot, N., & Scheen, A. (2015). Inhibiting or Antagonizing Glucagon: A Progress in Diabetes Care ? Diabetes, Obesity and Metabolism. doi:10.1111/dom.12480 Peer Reviewed verified by ORBi |
Scheen, A., Lefebvre, P., & Kulbertus, H. (2010). Prevention cardio-vasculaire: la "polypill", une solution pour vaincre l'inertie clinique et le manque d'observance? Revue Médicale de Liège, 65 (5-6), 267-72. Peer reviewed |
Scheen, A., & Lefebvre, P. (2009). Insuline glargine et cancer: une tempete dans un verre d'eau? Revue Médicale de Liège, 64 (9), 440-5. Peer reviewed |
Lefebvre, P., & Scheen, A. (2009). Les cas cliniques, une vision panachee de la medecine: de la simple anecdote a l'enseignement pratique. Revue Médicale de Liège, 64 (7-8), 357. Peer reviewed |
Radermecker, R., Philips, J.-C., Jandrain, B., Paquot, N., Lefebvre, P., & Scheen, A. (2008). Le cerveau, un organe gluco-dependant. Effets deleteres de l'hypoglycemie et de l'hyperglycemie. Revue Médicale de Liège, 63 (5-6), 280-6. Peer reviewed |
Scheen, A., Paquot, N., & Lefebvre, P. (2008). L'etude clinique du mois. United Kingdom Prospective Diabetes Study: 10 ans plus tard. Revue Médicale de Liège, 63 (10), 624-9. Peer reviewed |
Fysekidis, M., Hadjadj, S., Roussel, R., Bellili, N., Madani, S., Fumeron, F., Leblanc, H., Gautier, J., Weekers, L., Bauduceau, B., Charpentier, G., Virally, M., Alhenc-Gelas, F., Lefèbvre, P., & Marre, M. (September 2007). ACE I/D polymorphism predicts end stage renal disease and or mortality in type I diabetic patients except for those with already advanced nephropathy: the follow up of the Genesis/Genediab Studies. Diabetologia, 50 (Suppl. 1), 157-S158. Peer Reviewed verified by ORBi |
Paquot, N., Philips, J. C., Radermecker, R., & Lefèbvre, P. (2007). Actualites therapeutiques en diabetologie. Revue Médicale de Liège, 62 (5-6, May-Jun), 317-23. Peer reviewed |
Scheen, A., Luyckx, F., & Lefebvre, P. (2006). Comment j'explore...le syndrome metabolique par sa nouvelle definition dite de "consensus". Revue Médicale de Liège, 61 (1), 48-52. Peer reviewed |
Scheen, A., & Lefebvre, P. (2005). L'etude Proactive: prevention secondaire des accidents cardio-vasculaires par la pioglitazone chez le patient diabetique de type 2. Revue Médicale de Liège, 60 (11), 896-901. Peer reviewed |
Scheen, A., & Lefebvre, P. (2005). Le diabete sucre: epilogue. Revue Médicale de Liège, 60 (5-6), 628-31. Peer reviewed |
Krzentowski, G., Zhang, L., Albert, A., & Lefèbvre, P. (October 2004). Un autre regard sur les implications de l'etude DCCT. Annales d'Endocrinologie, 65 (5), 429-435. doi:10.1016/s0003-4266(04)95947-1 Peer Reviewed verified by ORBi |
Letiexhe, M., Desaive, C., Lefebvre, P., & Scheen, A. (2004). Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients. International Journal of Obesity, 28 (6), 821-3. doi:10.1038/sj.ijo.0802632 Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (2004). L'hypoglycemie reactive: un phenomene critique mysterieux, insidieux, mais non dangereux. Revue Médicale de Liège, 59 (4), 237-42. Peer reviewed |
Zhang, L., Krzentowski, G., Albert, A., & Lefèbvre, P. (July 2003). Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control. Diabetic Medicine: A Journal of the British Diabetic Association, 20 (7), 580-585. doi:10.1046/j.1464-5491.2003.00986.x Peer Reviewed verified by ORBi |
Scheen, A., Lefebvre, P., & Kulbertus, H. (2003). Comment je previens ... les maladies cardio-vasculaires par une approche pharmacologique combinee: y a-t-il place pour une polypill"?". Revue Médicale de Liège, 58 (9), 527-33. Peer reviewed |
Gaspard, U., Scheen, A., Endrikat, J., Buicu, C., Lefebvre, P., Gerlinger, C., & Heithecker, R. (2003). A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism. Contraception, 67 (6), 423-9. doi:10.1016/S0010-7824(02)00537-1 Peer Reviewed verified by ORBi |
Scheen, A., Paquot, N., Jandrain, B., & Lefebvre, P. (2002). L'hyperglycemie post-prandiale. I. Physiopathologie, consequences cliniques et approaches dietetiques. Revue Médicale de Liège, 57 (3), 138-41. Peer reviewed |
Scheen, A., & Lefebvre, P. (2002). Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents. Diabetes Care, 25 (1), 247-8. doi:10.2337/diacare.25.1.247 Peer Reviewed verified by ORBi |
Ludicke, F., Gaspard, U., Demeyer, F., Scheen, A., & Lefebvre, P. (2002). Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism. Contraception, 66 (6), 411-5. doi:10.1016/S0010-7824(02)00415-8 Peer Reviewed verified by ORBi |
Paquot, N., Scheen, A., Dirlewanger, M., Lefebvre, P., & Tappy, L. (2002). Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients. Obesity Research, 10 (3), 129-34. doi:10.1038/oby.2002.21 Peer Reviewed verified by ORBi |
Geenen, V., Kecha, O., Lefebvre, P., & Greiner, D. L. (2001). The role of the thymus in T cell self-tolerance of neuroendocrine principles and in development of neuroendocrine autoimmunity. Journal of Neuroimmunology, 118, 166. Peer Reviewed verified by ORBi |
Lefebvre, P., & Scheen, A. (2001). Obesity: causes and new treatments. Experimental and Clinical Endocrinology and Diabetes, 109 Suppl 2, 215-24. doi:10.1055/s-2001-18583 Peer Reviewed verified by ORBi |
Paquot, N., Schneiter, P., Scheen, A., Lefebvre, P., & Tappy, L. (2000). Assessment of postprandial hepatic glycogen synthesis from uridine diphosphoglucose kinetics in obese and lean non-diabetic subjects. International Journal of Obesity, 24 (10), 1297-302. doi:10.1038/sj.ijo.0801386 Peer Reviewed verified by ORBi |
Ordonez, A. J., Rodriguez-Castro, C., Zamora, J., Rubio, J. L., Scheen, A., Lefebvre, P., & Castillo, M. (2000). Developpement et utilisation d'un systeme de telemedecine pour le suivi medical des patients diabetiques. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 179-94. Peer Reviewed verified by ORBi |
Zhang, L., Krzentowski, G., Albert, A., & Lefèbvre, P. (2000). Risk of Developiment and progression of retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control. Diabete (Le). Peer Reviewed verified by ORBi |
Paquot, N., Scheen, A., & Lefebvre, P. (2000). Le controle glycemique chez le patient diabetique. Recommandations apres les etudes DCCT et UKPDI. Revue Médicale de Liège, 55 (5), 372-5. Peer reviewed |
Paquot, N., Castillo, M. J., Lefebvre, P., & Scheen, A. (2000). No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. Journal of Clinical Endocrinology and Metabolism, 85 (3), 1316-9. doi:10.1210/jc.85.3.1316 Peer Reviewed verified by ORBi |
Kecha, O., Martens, H., Brilot, F., Renard, C., Lefebvre, P., Greiner, D. L., & Geenen, V. (2000). Thymic insulin-related genes: role in T-lymphocyte development and self-tolerance of the insulin family. Pflügers Archiv: European Journal of Physiology, 440, 224. Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (2000). Antiobesity pharmacotherapy in the management of type 2 diabetes. Diabetes/Metabolism Research and Reviews, 16 (2), 114-24. doi:10.1002/(SICI)1520-7560(200003/04)16:2<114::AID-DMRR97>3.0.CO;2-O Peer Reviewed verified by ORBi |
Luyckx, F., Lefebvre, P., & Scheen, A. (2000). Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes and Metabolism, 26 (2), 98-106. Peer Reviewed verified by ORBi |
SCHEEN, A., Estrella, F., PHILIPS, J.-C., MARCHAND, M., & LEFEBVRE, P. (2000). Autonomic dysfunction evidenced by a squatting test in type 1 diabetic patients: effect of disease duration. Diabetologia, 43 (supp), 279. Peer Reviewed verified by ORBi |
Scheen, A., Rorive, M., Estrella, F., Weekers, L., & Lefebvre, P. (2000). Recommandations a propos du traitement de l'hypertension arterielle chez le patient diabetique. Revue Médicale de Liège, 55 (5), 376-82. Peer reviewed |
Estrella, F., Scheen, A., MARCHAND, M., Weekers, L., & Lefèbvre, P. (2000). Relationship between incipiens nephropathy and cardiac autonomic neuropathy in type 1 diabetes. Diabetes, 49 (sup. 1), 379-A380. Peer Reviewed verified by ORBi |
Luyckx, F., Scheen, A., Desaive, C., Thiry, A., & Lefebvre, P. (1999). Parallel reversibility of biological markers of the metabolic syndrome and liver steatosis after gastroplasty-induced weight loss in severe obesity. Journal of Clinical Endocrinology and Metabolism, 84 (11), 4293. doi:10.1210/jcem.84.11.6171-4 Peer Reviewed verified by ORBi |
Luyckx, F., Scheen, A., & Lefebvre, P. (1999). L'obesite feminine: souci esthetique ou probleme medical? Revue Médicale de Liège, 54 (4), 262-7. Peer reviewed |
Scheen, A., Paquot, N., & Lefebvre, P. (1999). Glucotoxicite et lipotoxicite, deux complices impliques dans le cercle vicieux du diabete de type 2. Revue Médicale de Liège, 54 (6), 535-8. Peer reviewed |
Geronooz, I., Scheen, A., & Lefebvre, P. (1999). Le diabete gestationnel: physiopathologie et signification pronostique pour la mere. Revue Médicale de Liège, 54 (5), 434-9. Peer reviewed |
Scheen, A., Luyckx, F., Desaive, C., & Lefebvre, P. (1999). Severe/extreme obesity: a medical disease requiring a surgical treatment? Acta Clinica Belgica, 54 (3), 154-61. doi:10.1080/17843286.1999.11754222 Peer Reviewed verified by ORBi |
Scheen, A., Letiexhe, M., & Lefebvre, P. (1999). Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme. Diabetes and Metabolism, 25 (2), 157-62. Peer Reviewed verified by ORBi |
Lefebvre, P., & Scheen, A. (1999). Glucose metabolism and the postprandial state. European Journal of Clinical Investigation, 29 Suppl 2, 1-6. doi:10.1046/j.1365-2362.1999.00003.x Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1999). Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes. Diabetes Care, 22 (9), 1568-77. doi:10.2337/diacare.22.9.1568 Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1999). Pharmacological treatment of obesity: present status. International Journal of Obesity, 23 Suppl 1, 47-53. doi:10.1038/sj.ijo.0800795 Peer Reviewed verified by ORBi |
Paolisso, G., Tagliamonte, M. R., Rizzo, M. R., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1999). Le vieillissement s'accompagne-t-il d'une diminution de la sensibilite a l'insuline? Roles de l'IGF1 et de la dehydroepiandrosterone. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 63-74. Peer Reviewed verified by ORBi |
Luyckx, F., Scheen, A., Letiexhe, M., Desaive, C., Gielen, J.-L., & Lefebvre, P. (1999). Comment je traite ... une obesite severe et ses anomalies metaboliques par une gastroplastie. Revue Médicale de Liège, 54 (3), 138-42. Peer reviewed |
Scheen, A., & Lefebvre, P. (1999). L'homeopathie est-elle superieure au placebo? Controverse a propos d'une meta-analyse des etudes controlees. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 154 (7-9), 295-304; discussion 304-7. Peer Reviewed verified by ORBi |
Lefebvre, P., & Scheen, A. (1999). State of current therapy and patient care in Europe. International Journal of Clinical Practice. Supplement, 107, 6-10. Peer Reviewed verified by ORBi |
Luyckx, F., Scheen, A., & Lefebvre, P. (1999). Non-alcoholic steatohepatitis. The Lancet, 354 (9186), 1298-9. doi:10.1016/S0140-6736(05)76068-2 Peer Reviewed verified by ORBi |
Kecha, O., Winkler, R., Martens, H., Collette, J., Lefebvre, P., Greiner, D. L., & Geenen, V. (1999). Thymic insulin-related polypeptides in diabetes-prone Bio-Breeding rats. Diabetologia, 42 (Suppl. 1), 29. Peer Reviewed verified by ORBi |
Scheen, A., Paquot, N., Letiexhe, M., & Lefebvre, P. (1999). Thiazolidinediones. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 213-29. Peer Reviewed verified by ORBi |
Gaspard, U., Wery, O., Scheen, A., Jaminet, C., & Lefebvre, P. (1999). Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric: the Journal of the International Menopause Society, 2 (2), 93-100. doi:10.3109/13697139909025572 Peer Reviewed verified by ORBi |
Paquot, N., Roulin, D., Schneiter, P., Ruiz, J., Lefèbvre, P., Pahud, P., & Tappy, L. (December 1998). Effects of Regular Insulin or Insulin Lispro on Glucose Metabolism after an Oral Glucose Load in Patients with Type 2 Diabetes Mellitus. Diabetes and Metabolism, 24 (6), 523-8. Peer Reviewed verified by ORBi |
Saint-Remy, A., Scheen, A., LEFEBVRE, P., & Rorive, G. (04 September 1998). Adverse effect of hyperinsulinemia on cardiovascular risk profile in middle-aged belgian population [Paper presentation]. Joint Scientific Meeting of the Dutch and Belgian Societies of hypertension, Mölndorf Hotel (Mölndorf), Luxembourg. |
Luyckx, F., Scheen, A., Proenza, A. M., Strosberg, A. D., Lefebvre, P., & Gielen, J.-L. (1998). Influence of the A-->G (-3826) uncoupling protein-1 gene (UCP1) variant on the dynamics of body weight before and after gastroplasty in morbidly obese subjects. International Journal of Obesity, 22 (12), 1244-5. doi:10.1038/sj.ijo.0800775 Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1998). Pharmaco-economie du diabete de type 2. Revue Médicale de Liège, 53 (5), 285-9. Peer reviewed |
Scheen, A., & Lefebvre, P. (1998). Oral antidiabetic agents. A guide to selection. Drugs, 55 (2), 225-36. doi:10.2165/00003495-199855020-00004 Peer Reviewed verified by ORBi |
Saint-Remy, A., Scheen, A., Jeanjean, M., LEFEBVRE, P., & Rorive, G. (1998). Adverse effect of hyperinsulinemia on cardiovascular risk profile in middle-aged belgian population. Acta Cardiologica, 53 (5), 299. Peer Reviewed verified by ORBi |
Luyckx, F., Desaive, C., Thiry, A., Dewe, W., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1998). Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. International Journal of Obesity, 22 (3), 222-6. doi:10.1038/sj.ijo.0800571 Peer Reviewed verified by ORBi |
Weekers, L., Scheen, A., & Lefebvre, P. (1998). Comment j'explore ... la nephropathie diabetique. Premiere partie: micro- et macro-albuminurie. Revue Médicale de Liège, 53 (8), 494-8. Peer reviewed |
Scheen, A., Triches, K., Luyckx, F., Letiexhe, M., & Lefebvre, P. (1998). Pharma clinics. Comment je traite ... un patient diabetique avec obesite severe. Revue Médicale de Liège, 53 (7), 386-9. Peer reviewed |
Scheen, A., & Lefebvre, P. (1998). Info-congres. Les lecons de la "United Kingdom Prospective Diabetes Study". Revue Médicale de Liège, 53 (9), 576-8. Peer reviewed |
Lefebvre, P., & Scheen, A. (1998). The postprandial state and risk of cardiovascular disease. Diabetic Medicine: A Journal of the British Diabetic Association, 15 Suppl 4, 63-8. doi:10.1002/(SICI)1096-9136(1998120)15:4+ Peer Reviewed verified by ORBi |
Philips, J.-C., Scheen, A., Firre, E., Robin, M., Cambier, P., & Lefebvre, P. (1998). Le cas clinique du mois. Une nephropathie galopante chez un patient diabetique de type 2. Revue Médicale de Liège, 53 (4), 171-4. Peer reviewed |
Radermecker, R., Scheen, A., Letiexhe, M., Lefebvre, P., & De Mol, P. (1998). Implications virales dans l'etiopathogenie du diabete de type 1: donnees actuelles. Revue Médicale de Liège, 53 (10), 597-602. Peer reviewed |
Scheen, A., Paquot, N., Triches, K., Luyckx, F., Letiexhe, M., & Lefebvre, P. (1998). Traitement ultime du diabete de type 2: insulinotherapie intensive ou chirurgie bariatrique? Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 81-97. Peer Reviewed verified by ORBi |
Luyckx, F., Scheen, A., Desaive, C., Dewe, W., Gielen, J.-L., & Lefebvre, P. (1998). Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes and Metabolism, 24 (4), 355-61. Peer Reviewed verified by ORBi |
Saint-Remy, A., Scheen, A., LEFEBVRE, P., JEANJEAN, M., & Rorive, G. (11 December 1997). Are fasting and postload insulin good markers of cardiovascular risk factors? [Paper presentation]. Conférence Inter hospitalière de Diabétologie / Endocrinologie, Liège, Belgium. |
Leclercq, D., & Lefèbvre, P. (July 1997). Distance learning and education for diabetes care. Journal of the Diabetic Association of India, 37 (3), 71-76. Peer reviewed |
Geenen, V., & Lefebvre, P. (1997). Expression of insulin-related peptides in the human thymus. International Diabetes Monitor, 9, 13-14. |
Luyckx, F., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1997). Le recepteur beta 3-adrenergique: un role dans la predisposition genetique a l'obesite et au diabete? Revue Médicale de Liège, 52 (11), 703-8. Peer reviewed |
Geenen, V., Kecha, O., Achour, I., Goxe, B., Winkler, R., & Lefèbvre, P. (1997). Molecular dissection of the insulin-like growth factor axis in the human thymus. Diabetologia, 40, 23. Peer Reviewed verified by ORBi |
Luyckx, F., Scheen, A., Gielen, J.-L., & Lefebvre, P. (1997). Comment j'explore ... le syndrome d'insulinoresistance grace a ses marqueurs biologiques. Revue Médicale de Liège, 52 (10), 686-91. Peer reviewed |
Kecha, O., Achour, I., Martens, H., Winkler, R., Lefebvre, P., & Geenen, V. (1997). Characterization of the insulin-like growth (IGF) axis in the human thymus. In The Endocrine Society, Proceedings of the 77th Annual Meeting of the Endocrine Society (pp. 150 (P3-259). Peer reviewed |
Letiexhe, M., Scheen, A., & Lefebvre, P. (1997). Plasma leptin levels, insulin secretion, clearance and action on glucose metabolism in anorexia nervosa. Eating and Weight Disorders, 2 (2), 79-86. Peer Reviewed verified by ORBi |
Bozet, M.-C., Gerard, P., Scheen, A., Lefebvre, P., & Castillo, M. J. (1997). Determination rapide par immunodosage de l'hemoglobine glyquee sur sang capillaire comparee a une methode d'affinite pour le boronate et capture d'ions sur sang veineux. Annales de Biologie Clinique, 55 (2), 139-44. Peer Reviewed verified by ORBi |
Beguin, Y., Grek, V., Weber, G., Sautois, B., Paquot, N., Pereira-Martins, M., Scheen, A., Lefèbvre, P., & Fillet, G. (1997). Acute Functional Iron Deficiency in Obese Subjects During a Very-Low-Energy All-Protein Diet. American Journal of Clinical Nutrition, 66 (1), 75-9. doi:10.1093/ajcn/66.1.75 Peer Reviewed verified by ORBi |
Overkamp, D., Gautier, J. F., Renn, W., Pickert, A., Scheen, A., Schmulling, R. M., Eggstein, M., & Lefebvre, P. (1997). Glucose turnover in humans in the basal state and after intravenous glucose: a comparison of two models. American Journal of Physiology, 273 (2 Pt 1), 284-96. doi:10.1152/ajpendo.1997.273.2.e284 Peer Reviewed verified by ORBi |
Piéron, M., Scheen, A., Corhay, J.-L., Radermecker, M., & Lefebvre, P. (1997). Reactivite bronchique chez les patients diabetiques. Revue des Maladies Respiratoires, 14 (5), 379-85. Peer Reviewed verified by ORBi |
Hodzic, D., Delacroix, L., Willemsen, P., Bensbaho, K., Collette, J., Broux, R., Lefebvre, P., Legros, J.-J., Grooteclaes, M., & Winkler, R. (1997). Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma. Hormone and Metabolic Research, 29 (11), 549-55. doi:10.1055/s-2007-979099 Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., Paolisso, G., & Lefebvre, P. (1996). Exhaustion of blood glucose response and enhancement of insulin response after repeated glucagon injections in type-2 diabetes: potentiation by progressive hyperglycemia. Annales d'Endocrinologie, 57 (5), 395-402. Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1996). Le diabete non insulinodependant: de la physiopathologie au traitement. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 151 (7-9), 395-402; discussion 402-5. Peer Reviewed verified by ORBi |
Scheen, A., Castillo, M. J., & Lefebvre, P. (1996). Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement. Diabetes and Metabolism, 22 (6), 455-8. Peer Reviewed verified by ORBi |
Gautier, J. F., Pirnay, F., Lacroix, M., Mosora, F., Scheen, A., Cathelineau, G., & Lefebvre, P. (1996). Changes in breath 13CO2/12CO2 during exercise of different intensities. Journal of Applied Physiology, 81 (3), 1096-102. doi:10.1152/jappl.1996.81.3.1096 Peer Reviewed verified by ORBi |
Geenen, V., Achour, I., Kecha, O., Greiner, D. L., Rossini, A. A., & Lefebvre, P. (1996). Thymic insulin-like growth factors (IGFs) in man and in an animal model of autoimmune IDDM. Diabetologia, 39, 15. Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1996). Insulin action in man. Diabetes and Metabolism, 22 (2), 105-10. Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1996). The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose Level. Journal of Clinical Endocrinology and Metabolism, 81 (5), 1975-8. doi:10.1210/jc.81.5.1975 Peer Reviewed verified by ORBi |
Scheen, A., Castillo, M. J., & Lefebvre, P. (1996). Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes and Metabolism, 22 (6), 397-406. Peer Reviewed verified by ORBi |
Kaiser, M.-J., Achour, I., Kecha, O., Goxe, B., De Groote, D., Lefebvre, P., & Geenen, V. (1995). Vieillissement, défenses immunitaires at axe somatotrope-facteurs de croissance apparentés à l'insuline. Médecine et Hygiène, 53, 1608-1610. Peer Reviewed verified by ORBi |
Scheen, A., Letiexhe, M., & Lefebvre, P. (1995). Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance. Diabetic Medicine: A Journal of the British Diabetic Association, 12 (11), 985-9. doi:10.1111/j.1464-5491.1995.tb00410.x Peer Reviewed verified by ORBi |
Lefebvre, P., & Scheen, A. (1995). Improving the action of insulin. Clinical and Investigative Medicine, 18 (4), 340-7. Peer Reviewed verified by ORBi |
Pirnay, F., Scheen, A., Gautier, J. F., Lacroix, M., Mosora, F., & Lefebvre, P. (1995). Exogenous glucose oxidation during exercise in relation to the power output. International Journal of Sports Medicine, 16 (7), 456-60. doi:10.1055/s-2007-973037 Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1995). Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology. Diabète et Métabolisme, 21 (1), 3-25. Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1995). Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 80 (2), 393-9. doi:10.1210/jcem.80.2.7852495 Peer Reviewed verified by ORBi |
Bozet, M.-C., Scheen, A., Gerard, P., Castillo, M. J., & Lefebvre, P. (1995). Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabète et Métabolisme, 21 (5), 353-9. Peer Reviewed verified by ORBi |
Scheen, A., Paquot, N., Letiexhe, M., Castillo, M. J., & Lefebvre, P. (1995). Comment explorer la sensibilite a l'insuline chez l'homme? Annales d'Endocrinologie, 56 (5), 523-30. Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1995). Antihyperglycaemic agents. Drug interactions of clinical importance. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 12 (1), 32-45. doi:10.2165/00002018-199512010-00003 Peer Reviewed verified by ORBi |
Paolisso, G., Scheen, A., & Lefebvre, P. (1995). Glucose handling, diabetes and ageing. Hormone Research, 43 (1-3), 52-7. doi:10.1159/000184237 Peer Reviewed verified by ORBi |
Geenen, V., Vandersmissen, E., Martens, H., Goxe, B., Kecha, O., Legros, J.-J., Lefebvre, P., Benhida, A., Rentier-Delrue, F., & Martial, J. (1995). Cellular and molecular aspects of thymic T-cell education to neurohypophysial peptides. In S. Yoshida, T. Saito (Ed.), ... K. Kurokawa (Ed.), Neurohypophysis - Recent Progress of Vasopressin and Oxytocin Research (pp. 309-319). New York, United States: Elsevier Science. |
Geenen, V., Goxe, B., Martens, H., Vandersmissen, E., Vanneste, Y., Achour, I., Kecha, O., & Lefebvre, P. (1995). Cryptocrine Signaling in the Thymus Network and T Cell Education to Neuroendocrine Self-Antigens. Journal of Molecular Medicine, 73 (9), 449-55. doi:10.1007/BF00202263 Peer Reviewed verified by ORBi |
Letiexhe, M., Scheen, A., Gerard, P., Desaive, C., & Lefebvre, P. (1995). Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. Journal of Clinical Endocrinology and Metabolism, 80 (2), 364-9. doi:10.1210/jcem.80.2.7852491 Peer Reviewed verified by ORBi |
Scheen, A., Paquot, N., Letiexhe, M., Paolisso, G., Castillo, M. J., & Lefebvre, P. (1995). Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies. International Journal of Obesity, 19 Suppl 3, 14-20. Peer Reviewed verified by ORBi |
Letiexhe, M., Scheen, A., Gerard, P., Desaive, C., & Lefebvre, P. (1994). Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. International Journal of Obesity, 18 (5), 295-300. Peer Reviewed verified by ORBi |
Saint-Remy, A., Beck, D., Lefèbvre, P., Jeanjean, M., & Rorive, G. (1994). Epidemiology of insulin resistance and hypertension in adults - MONICA BELLUX- preliminary results. Cardiovascular Disease Epidemiology Newsletter, Amercian Heart Association, 49, 50-51. Peer reviewed |
Paolisso, G., Scheen, A., Cozzolino, D., Di Maro, G., Varricchio, M., D'Onofrio, F., & Lefebvre, P. (1994). Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. Journal of Clinical Endocrinology and Metabolism, 78 (6), 1510-4. doi:10.1210/jcem.78.6.8200955 Peer Reviewed verified by ORBi |
Scheen, A., de Magalhaes, A. C., Salvatore, T., & Lefebvre, P. (1994). Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man. European Journal of Clinical Investigation, 24 Suppl 3, 50-4. doi:10.1111/j.1365-2362.1994.tb02257.x Peer Reviewed verified by ORBi |
Lefebvre, P., Paolisso, G., & Scheen, A. (1994). Magnesium et metabolisme glucidique. Thérapie, 49 (1), 1-7. Peer Reviewed verified by ORBi |
Scheen, A., Desaive, C., & Lefebvre, P. (1994). Therapy for obesity--today and tomorrow. Bailliere's Clinical Endocrinology and Metabolism, 8 (3), 705-27. doi:10.1016/S0950-351X(05)80292-7 Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., & Lefebvre, P. (1994). Metabolic clearance rate of insulin in type 2 diabetic patients treated with combined insulin and sulfonylurea therapy. Revista Espanola de Fisiologia, 50 (1), 27-34. Peer Reviewed verified by ORBi |
Marfella, R., Salvatore, T., Giugliano, D., Di Maro, G., Giunta, R., Torella, R., Juchmes, J., Scheen, A., & Lefebvre, P. (1994). Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM. Diabetes Care, 17 (2), 149-51. doi:10.2337/diacare.17.2.149 Peer Reviewed verified by ORBi |
Lefebvre, P., & Scheen, A. (1994). The use of acarbose in the prevention and treatment of hypoglycaemia. European Journal of Clinical Investigation, 24 Suppl 3, 40-4. doi:10.1111/j.1365-2362.1994.tb02255.x Peer Reviewed verified by ORBi |
Geenen, V., Martens, H., Vandersmissen, E., Kecha, O., Benhida, A., Cormann-Goffin, N., Lefebvre, P., & Franchimont, P. (1994). Thymic neuroendocrine self peptides and T-cell selection. In E. Heinen, M.-P. Defresne, J. Boniver, ... V. Geenen (Eds.), In Vivo Immunology - Regulatory Processes during Lymphopoiesis and Immunopoiesis. New York, United States: Plenum. doi:10.1007/978-1-4615-2492-2_4 |
Geenen, V., Martens, H., Kecha, O., Achour, I., Lefebvre, P., Franchimont, P., & Goxe, B. (1994). Les choix stratégiques actuels dans la prévention du processus diabétogène auto-immun. Médecine et Hygiène, 52, 1655-1658. Peer Reviewed verified by ORBi |
Gautier, J. F., Pirnay, F., Jandrain, B., Lacroix, M., Mosora, F., Scheen, A., Cathelineau, G., & Lefebvre, P. (1994). Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade. European Journal of Applied Physiology and Occupational Physiology, 68 (5), 406-12. doi:10.1007/BF00843737 Peer Reviewed verified by ORBi |
Duysinx, B., Scheen, A., Gerard, P., Letiexhe, M., Paquot, N., & Lefebvre, P. (1994). Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility. Diabète et Métabolisme, 20 (4), 425-32. Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., Jandrain, B., & Lefebvre, P. (1994). Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity. International Journal of Obesity, 18 (1), 47-53. Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1993). Pharmacological treatment of the obese diabetic patient. Diabète et Métabolisme, 19 (6), 547-59. Peer Reviewed verified by ORBi |
Geenen, V., Achour, I., Martens, H., Lefebvre, P., & Franchimont, P. (1993). Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. In The Endocrine Society, Proceedings of the 75th Annual Meeting of the Endocrine Society (pp. 879). Peer reviewed |
Beck, D., Saint-Remy, A., LEFEBVRE, P., Jeanjean, M., & Rorive, G. (1993). Insulinemia and glycemia in free antihypertensive medicated adults - MONICA BELLUX. Acta Clinica Belgica, 6, 423. Peer Reviewed verified by ORBi |
Scheen, A., Jandrain, B., Humblet, D., Jaminet, C. B., Gaspard, U., & Lefebvre, P. (1993). Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism. Fertility and Sterility, 59 (4), 797-802. doi:10.1016/s0015-0282(16)55862-2 Peer Reviewed verified by ORBi |
Scheen, A., Castillo, M. J., & Lefebvre, P. (1993). Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes. Acta Clinica Belgica, 48 (4), 259-68. doi:10.1080/17843286.1993.11718317 Peer Reviewed verified by ORBi |
Gautier, J. F., Pirnay, F., Jandrain, B., Lacroix, M., Mosora, F., Scheen, A., & Lefebvre, P. (1993). Endogenous substrate oxidation during exercise and variations in breath 13CO2/12CO2. Journal of Applied Physiology, 74 (1), 133-8. doi:10.1152/jappl.1993.74.1.133 Peer Reviewed verified by ORBi |
Geenen, V., Achour, I., Robert, F., Vandersmissen, E., Sodoyez, J.-C., Defresne, M.-P., Boniver, J., Lefebvre, P., & Franchimont, P. (1993). Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus, 21 (2), 115-127. Peer Reviewed verified by ORBi |
Letiexhe, M., Scheen, A., Gerard, P., Bastens, B. H., Pirotte, J., Belaiche, J., & Lefebvre, P. (1993). Insulin secretion, clearance, and action on glucose metabolism in cirrhotic patients. Journal of Clinical Endocrinology and Metabolism, 77 (5), 1263-8. doi:10.1210/jcem.77.5.8077319 Peer Reviewed verified by ORBi |
LETIEXHE, M., SCHEEN, A., PAQUOT, N., DESAIVE, C., & LEFEBVRE, P. (1993). Effects of moderate vs marked weight loss on insulin sensitivity and androgenic markers in obese women. In H. Ditschuneit, F. A. Gries, H. Hauner, V. Schusdziarra, ... J. G. Wechsler (Eds.), Obesity in Europe (pp. 469-473). John Libbey & Company Ltd. |
Paolisso, G., Sgambato, S., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1992). Insulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery. European Journal of Medicine, 1 (5), 261-7. Peer Reviewed verified by ORBi |
Lefebvre, P., & Scheen, A. (1992). Management of non-insulin-dependent diabetes mellitus. Drugs, 44 Suppl 3, 29-38. doi:10.2165/00003495-199200443-00005 Peer Reviewed verified by ORBi |
Pochet, T. F. J., Gérard, P., Fossion, A., Pirotton, M., Scheen, A., Lefebvre, P., & Juchmes, J. (1992). Squatting to standing: an unusual but powerful postural manoeuvre to investigate human arterial blood pressure regulation. Archives of Physiology and Biochemistry, 100 (5), 31-51. doi:10.3109/13813459209000732 Peer Reviewed verified by ORBi |
Moutschen, M., Scheen, A., & Lefebvre, P. (1992). Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabète et Métabolisme, 18 (3), 187-201. Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1992). Assessment of insulin resistance in vivo: application to the study of type 2 diabetes. Hormone Research, 38 (1-2), 19-27. doi:10.1159/000182467 Peer Reviewed verified by ORBi |
Lilet, H., Krzentowski, G., Bodson, A., Scheen, A., & Lefebvre, P. (1991). Absence de benefice de l'administration intermittente de l'insuline lors d'un traitement par pompe a perfusion sous-cutanee chez le diabetique de type-1. Diabète et Métabolisme, 17 (3), 363-72. Peer Reviewed verified by ORBi |
Geenen, V., Robert, F., Legros, J.-J., Defresne, M.-P., Boniver, J., Martial, J., Lefebvre, P., & Franchimont, P. (1991). Neuroendocrine-Immunology: from systemic interactions to the immune tolerance of self neuroendocrine functions. Acta Clinica Belgica, 46, 135-141. doi:10.1080/17843286.1991.11718156 Peer Reviewed verified by ORBi |
Scheen, A., Paolisso, G., Salvatore, T., & Lefebvre, P. (1991). Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine. Diabetes Care, 14 (4), 325-32. doi:10.2337/diacare.14.4.325 Peer Reviewed verified by ORBi |
Geenen, V., Martens, H., Robert Françoise, Legros, J.-J., Degiovanni, G., Defresne, M.-P., Boniver, J., Martial, J., Lefèbvre, P., & Franchimont, P. (1991). Thymic cryptocrine signaling and the immune recognition of self neuroendocrine functions. Progress in Neuroendocrinimmunology, 4, 135-142. Peer reviewed |
Paolisso, G., Scheen, A., Giugliano, D., Sgambato, S., Albert, A., Varricchio, M., D'Onofrio, F., & Lefebvre, P. (1991). Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. Journal of Clinical Endocrinology and Metabolism, 72 (3), 607-15. doi:10.1210/jcem-72-3-607 Peer Reviewed verified by ORBi |
Jandrain, B., Lefèbvre, P., Pirnay, F., & Scheen, A. (1990). Alimentation avant, pendant et après l'exercice physique chez le sujet normal et diabétique. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 159-70. |
Paolisso, G., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1990). Magnesium and glucose homeostasis. Diabetologia, 33 (9), 511-4. doi:10.1007/BF00404136 Peer Reviewed verified by ORBi |
Jandrain, B., Humblet, D., Jaminet, C. B., Scheen, A., Gaspard, U., & Lefebvre, P. (1990). Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial. American Journal of Obstetrics and Gynecology, 163 (1 Pt 2), 378-81. doi:10.1016/0002-9378(90)90586-V Peer Reviewed verified by ORBi |
Paolisso, G., Buonocore, S., Gentile, S., Sgambato, S., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1990). Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age. Diabetologia, 33 (5), 272-7. doi:10.1007/BF00403320 Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., Gualda, P., & Lefebvre, P. (1989). Papel de la insulina y hormonas de contra-regulacion en las alteraciones metabolicas por deprivacion de insulina en pacientes diabeticos. Revista Espanola de Fisiologia, 45 (1), 53-9. Peer Reviewed verified by ORBi |
Scheen, A., & Lefebvre, P. (1989). Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas. Diabetes Research and Clinical Practice, 6 (4), 33-42; discussion S42-3. doi:10.1016/0168-8227(89)90076-4 Peer Reviewed verified by ORBi |
Paolisso, G., Scheen, A., Albert, A., & Lefebvre, P. (1989). Effects of pulsatile delivery of insulin and glucagon in humans. American Journal of Physiology, 257 (5 Pt 1), 686-96. Peer Reviewed verified by ORBi |
Scheen, A., Gillet, J., Rosenthaler, J., Guiot, J., Henrivaux, P., Jandrain, B., & Lefebvre, P. (1989). Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients. Diabetologia, 32 (11), 801-9. doi:10.1007/BF00264911 Peer Reviewed verified by ORBi |
Jandrain, B., Pirnay, F., Lacroix, M., Mosora, F., Scheen, A., & Lefebvre, P. (1989). Effect of osmolality on availability of glucose ingested during prolonged exercise in humans. Journal of Applied Physiology, 67 (1), 76-82. doi:10.1152/jappl.1989.67.1.76 Peer Reviewed verified by ORBi |
Jandrain, B., Pirnay, F., Scheen, A., & Lefebvre, P. (1988). Adaptations au sport du diabetique traite par insuline. Diabète et Métabolisme, 14 (2), 127-35. Peer Reviewed verified by ORBi |
Giugliano, D., Torella, R., Scheen, A., Lefebvre, P., & D'Onofrio, F. (1988). Prostaglandines, secretion d'insuline et diabete sucre. Diabète et Métabolisme, 14 (6), 721-7. Peer Reviewed verified by ORBi |
Scheen, A., Castillo, M., & Lefebvre, P. (1988). Insulin sensitivity in anorexia nervosa: a mirror image of obesity? Diabetes/Metabolism Reviews, 4 (7), 681-90. doi:10.1002/dmr.5610040705 Peer Reviewed verified by ORBi |
Paolisso, G., Sgambato, S., Torella, R., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1988). Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism, 66 (6), 1220-6. doi:10.1210/jcem-66-6-1220 Peer Reviewed verified by ORBi |
Paquot, N., Scheen, A., Franchimont, P., & Lefebvre, P. (1988). The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabète et Métabolisme, 14 (1), 31-6. Peer Reviewed verified by ORBi |
Scheen, A., Paquot, N., & Lefebvre, P. (1988). Perspectives concernant les voies d'administration inhabituelles de l'insuline. Les voies orale, rectale et nasale. Annales d'Endocrinologie, 49 (4-5), 386-90. Peer Reviewed verified by ORBi |
Paolisso, G., Sgambato, S., Giugliano, D., Torella, R., Varricchio, M., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1988). Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia, 31 (12), 910-5. doi:10.1007/BF00265376 Peer Reviewed verified by ORBi |
PAQUOT, N., Henrivaux, Scheen, A., JANDRAIN, B., & LEFEBVRE, P. (03 April 1987). Changes in plasma and erythrocyte magnesium concentrations during protein- sparing modified fast (PSMF) in obese subjects: comparison Alburone versus Nutroclin VLC [Poster presentation]. Symposium "Magnesium in daily practice: clinical and therapeutical implications", Anvers, Belgium. |
PAQUOT, N., SCHEEN, A., & Lefèbvre, P. (April 1987). Effets métaboliques et hormonaux d'un spray nasal d'insuline chez le sujet normal. Acta Clinica Belgica, 42 (5). Peer Reviewed verified by ORBi |
Paolisso, G., Scheen, A., Luyckx, A. S., & Lefebvre, P. (1987). Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man. American Journal of Physiology, 252 (1 Pt 1), 1-7. doi:10.1152/ajpendo.1987.252.1.e1 Peer Reviewed verified by ORBi |
Castillo, M., Scheen, A., Paolisso, G., & Lefebvre, P. (1987). The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion. Acta Endocrinologica, 116 (3), 364-72. doi:10.1530/acta.0.1160364 Peer Reviewed verified by ORBi |
Scheen, A., Jaminet, C., Luyckx, A. S., & Lefebvre, P. (1987). Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 25 (2), 70-6. Peer Reviewed verified by ORBi |
Scheen, A., Henrivaux, P., Jandrain, B., Paolisso, G., & Lefebvre, P. (1987). Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII. Diabetes Care, 10 (5), 567-72. doi:10.2337/diacare.10.5.567 Peer Reviewed verified by ORBi |
Paolisso, G., Sgambato, S., Passariello, N., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1987). Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels. Diabetes, 36 (5), 566-70. doi:10.2337/diab.36.5.566 Peer Reviewed verified by ORBi |
Paolisso, G., Giugliano, D., Scheen, A., Franchimont, P., D'Onofrio, F., & Lefebvre, P. (1987). Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. Acta Endocrinologica, 115 (2), 161-9. doi:10.1530/acta.0.1150161 Peer Reviewed verified by ORBi |
Scheen, A., Henrivaux, P., Jandrain, B., & Lefebvre, P. (1987). U-100 insulin gives some protection against metabolic deterioration due to CSII interruption. Diabetes Care, 10 (6), 707-11. doi:10.2337/diacare.10.6.707 Peer Reviewed verified by ORBi |
Paolisso, G., Sgambato, S., Passariello, N., Giugliano, D., Scheen, A., D'Onofrio, F., & Lefebvre, P. (1986). Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia, 29 (9), 644-7. doi:10.1007/BF00869264 Peer Reviewed verified by ORBi |
Luyckx, A. S., Daubresse, J. C., Jaminet, C., Scheen, A., & Lefebvre, P. (1986). Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin. Acta Diabetologica Latina, 23 (2), 101-6. doi:10.1007/BF02624669 Peer Reviewed verified by ORBi |
Paolisso, G., Scheen, A., Verdin, E., Luyckx, A. S., & Lefebvre, P. (1986). Insulin oscillations per se do not affect glucose turnover parameters in normal man. Journal of Clinical Endocrinology and Metabolism, 63 (2), 520-5. doi:10.1210/jcem-63-2-520 Peer Reviewed verified by ORBi |
Lefebvre, P., Luyckx, A., Krzentowski, G., Jandrain, B., Pirnay, F., Crielaard, J.-M., Mosora, F., Lacroix, M., & Pallikarakis, N. (1986). Utilisation d'une charge orale de glucose donnée avant, pendant ou après un exercice musculaire prolongé. Cahiers de Nutrition et de Diététique, XXI, 129-131. Peer reviewed |
Castillo, M., Scheen, A., Lefebvre, P., & Luyckx, A. S. (1985). Insulin-stimulated glucose disposal is not increased in anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 60 (2), 311-4. doi:10.1210/jcem-60-2-311 Peer Reviewed verified by ORBi |
Scheen, A., Castillo, M., Jandrain, B., Krzentowski, G., Henrivaux, P., Luyckx, A. S., & Lefebvre, P. (1984). Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care, 7 (4), 338-42. doi:10.2337/diacare.7.4.338 Peer Reviewed verified by ORBi |
Scheen, A., Lefebvre, P., & Luyckx, A. S. (1984). Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients. European Journal of Clinical Pharmacology, 26 (4), 471-4. doi:10.1007/BF00542143 Peer Reviewed verified by ORBi |
Scheen, A., Luyckx, A. S., Fossion, A., & Lefebvre, P. (1983). Effect of protein-supplemented fasting on the fuel-hormone response to prolonged exercise in obese subjects. International Journal of Obesity, 7 (4), 327-37. Peer Reviewed verified by ORBi |
Castillo, M. J., Scheen, A., Luyckx, A. S., & Lefebvre, P. (1983). Blood collection while using a continuous glucose analyzer without insertion of an additional venous catheter. Diabetologia, 25 (2), 120-2. doi:10.1007/BF00250899 Peer Reviewed verified by ORBi |
Krzentowski, G., Scheen, A., Castillo, M., Luyckx, A. S., & Lefebvre, P. (1983). A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia, 24 (5), 314-8. doi:10.1007/BF00251815 Peer Reviewed verified by ORBi |
Scheen, A., Pirnay, F., Luyckx, A. S., & Lefebvre, P. (1983). Metabolic adaptation to prolonged exercise in severely obese subjects. International Journal of Obesity, 7 (3), 221-9. Peer Reviewed verified by ORBi |
Scheen, A., Luyckx, A. S., Scheen, M., & Lefebvre, P. (1982). Hormonal and metabolic adaptation to protein-supplemented fasting in obese subjects. International Journal of Obesity, 6 (2), 165-74. Peer Reviewed verified by ORBi |
Pirnay, F., Krzentowski, G., Crielaard, J.-M., Pallikarakis, N., Lacroix, M., Mosora, F., Luyckx, A., & Lefèbvre, P. (1982). Fate of exogneous glucose metabolism during exercise of different intensities in humans. Journal of Applied Physiology, 53, 1620-1624. Peer Reviewed verified by ORBi |
Pirnay, F., Krzentowski, G., Crielaard, J.-M., Pallikarakis, N., Lacroix, M., Mosora, F., Luyckx, A., & Lefèbvre, P. (1981). Oxidation and orally administrated 'naturally labeled 13C-glucose' during prolonged muscular exercise : 100g versus 4 x 250g. In J. Poortmans, Biochemistry of exercise IV-A : 4th International Symposium of Biochemistry on Exercise, June 19-22, 1979, Bruxelles (pp. 196-207). Baltimore, United States - Maryland: University Park Press. |
Luyckx, A. S., Guerten, D., Scheen, A., Delporte, J.-P., Lefebvre, P., & Jaminet, F. (1981). Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects. Acta Diabetologica Latina, 18 (3), 259-66. doi:10.1007/BF02047898 Peer Reviewed verified by ORBi |